Merit Medical Systems (MMSI)
(Delayed Data from NSDQ)
$85.95 USD
+1.56 (1.85%)
Updated Jul 9, 2024 04:00 PM ET
After-Market: $85.95 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth C Momentum B VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
MMSI 85.95 +1.56(1.85%)
Will MMSI be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for MMSI based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MMSI
Cardinal Health (CAH) Recalls Kits Containing Shenli's Syringes
Merit Medical (MMSI) Inks Deal to Boost Endoscopy Portfolio
MMSI: What are Zacks experts saying now?
Zacks Private Portfolio Services
Merit Medical (MMSI) Hits 52-Week High: What's Aiding It?
Three Reasons to Retain Merit Medical (MMSI) Stock for Now
Here's Why Merit Medical (MMSI) is a Strong Growth Stock
Other News for MMSI
Analyst Expectations For Merit Medical Systems's Future
Merit Medical management to meet with Barrington
Merit Medical management to meet with Barrington
Merit Medical Systems: A Strong Buy on Solid Track Record and Robust Growth Prospects
Merit Medical initiated with bullish view at Baird, here's why